Real-world treatment outcomes and clinicopathologic and molecular determinants of response to first-line lenvatinib in patients with advanced follicular cell-derived thyroid cancer by Kara M. Ruicci, Yangqing Deng, Tian Xiao, Antoine Eskander, David Goldstein, Ozgur Mete, Aruz Mesci, Jelena Lukovic, Monika K. Krzyzanowska, Carly C. Barron, Lucy X. Ma

Get full text